Molecular biology and biochemistry

Annals of Otology, Rhinology and Laryngology

Volumn 111, Issue 3 SUPPL., 2002, Pages 52-61

  Ryan, Allen F ^a   Bakaletz, Lauren O ^a   Juhn, Steven K ^a   Jung, Timothy T K ^a   Li, Jian Dong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BACTERIAL COLONIZATION; CHOLESTEATOMA; CHRONIC INFLAMMATION; CONFERENCE PAPER; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036121330     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/00034894021110s308     Document Type: Conference Paper

References (88)

1. Otitis media with effusion is an inflammatory condition
2. Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor
3. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions
4. Interleukin-8 and chemotactic activity of middle ear effusions
5. Interleukin-8 concentration predicts the neutrophil count in middle ear effusion
6. Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media
7. Serum interleukin-6 in bacterial and nonbacterial acute otitis media
8. Interferon production by leukocytes in children with otitis media with effusion
9. Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media
10. Competitive PCR for cytokine genes during experimental otitis media
11. Expression of nitric oxide synthase in the mouse middle ear mucosa during immune-mediated chronic otitis media
12. The role of IL-1 beta in murine model of otitis media with effusion
13. In vivo induction and regulation of interleukin-8-like chemokine GRO/CINC-1 in rat middle ear
14. Murine model of interleukin-8-induced otitis media
15. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions
16. Effect of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig
17. Effects of platelet activating factor on vascular permeability of the middle ear mucosa
18. Early-response cytokine expression in adult middle ear effusions
19. Platelet-activating factor and leukotrienes in acute otitis media, secretory otitis media, and chronic otitis media on the acute exacerbation
20. Eicosanoid synthesis and inactivation in healthy and infected chinchilla middle ears
21. Transforming growth factor-β expression in otitis media with effusion
22. Expression of genes encoding growth factor receptors in the middle ear mucosa
23. Influence of growth factors on the middle ear mucosa
24. Implantation of cells transfected with the FGF-1 gene induces middle ear mucosal proliferation
25. Molecular markers for bone formation during bacterial otitis media in the rat
26. Epidermal growth factor and basic fibroblast growth factor are induced in guinea pig tympanic membrane following traumatic perforation
27. Neutralizing antibodies against basic fibroblast growth factor influence the healing of traumatic tympanic membrane perforations
28. Expression of protectin (CD59), an inhibitor of the membrane attack complex of complement in otitis media with effusion
29. Concentration of nitric oxide in middle ear effusion
30. The analysis of middle ear effusion for matrix metalloproteinases 2 and 9
31. Effect of cytokines on iNOS expression of middle ear epithelial cells
32. Superoxide dismutase in animal model of otitis media
33. Nitric oxide: Mediator of endotoxin-induced middle ear effusions
34. Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion
35. Effect of inhibitors of leukotriene and/or platelet-activating factor on experimental otitis media with effusion
36. Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation
37. Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells
38. Effect of oxatomide on otitis media with effusion - An experimental study
39. Evaluation of the effect of erythromycin on otitis media with effusion in experimental rat models
40. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas
41. Expression of transforming growth factor-α (TGF-α) in cholesteatoma
42. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma
43. Interleukin-1 α, interleukin-1β, and interleukin-8 gene expression in human aural cholesteatomas
44. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas
45. Clinical and biochemical studies of bone destruction in cholesteatoma
46. Signal transduction pathway in human middle ear cholesteatoma
47. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma
48. Expression of P53 protein in human middle ear cholesteatomas: Pathogenetic implications
49. Nonencapsulated Haemophilus influenzae in Aboriginal infants with otitis media: Prolonged carriage of P2 porin variants and evidence for horizontal P2 gene transfer
50. Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae
51. Secretion of the Haemophilus influenzae HMW1 and HMW2 adhesins involves a periplasmic intermediate and requires the HMWB and HMWC proteins
52. Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein
53. Variation in expression of the Haemophilus influenzae HMW adhesins: A prokaryotic system reminiscent of eukaryotes
54. hgpB, a gene encoding a second Haemophilus influenzae hemoglobin- and hemoglobinhaptoglobin-binding protein
55. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcuspneumoniae
56. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae
57. Mapping of a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis
58. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes
59. Characterization of Moraxella (Branhamella) catarrhalis lbpB, lbpA, and lactoferrin receptor orf3 isogenic mutants
60. Use of an isogenic mutant constructed in Moraxella catarrhalis to identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6
61. Mucin gene expression in the immortalized human middle ear epithelial cells
62. Effects of retinoic acid, triiodothyronine and hydrocortisone on mucin and lysozyme expression in passage-2 normal human middle ear epithelial cells
63. Expression of glycoconjugates in human eustachian tubes with otitis media
64. Heterogeneity in the protein cores of mucins isolated from human middle ear effusions: Evidence for expression of different mucin gene products
65. Expression of mucin genes in otitis media
66. Mucin gene expression in human middle ear
67. Signal transduction mechanisms involved in bacteria-induced mucin overproduction
68. Activation of NF-kB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for P aeruginosa-induced mucin overproduction in epithelial cells
69. Oxygen radicals as second messengers for bacteria-induced up-regulation of mucin gene transcription
70. Alterations of mucin gene expression in the transition of acute to mucoid otitis media
71. Evidence obtained by confocal microscopy that links phosphorylation of tyrosine with nontypeable Haemophilus influenzae adherence and actin nucleation
72. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein
73. Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear
74. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: Relationship to keratinocyte proliferation, differentiation, and programmed cell death
75. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis
76. Expression of PLC-gamma 1 in experimental cholesteatoma
77. Expression of immunoregulatory cytokines during acute and chronic middle ear immune response
78. MEK1/2-MAPK pathway is involved in IL-1-induced down-regulation of surfactant B
79. Inflammatory NO involvement in auditory function
80. The role of the transcription factor NF-κB in the expression of IL-8 from human adenoidal fibroblasts
81. Retinoic acid disturbs mouse middle ear development in a stage-dependent fashion
82. Embryological and genetic aspects of middle ear development
83. Correlation between loss of middle ear bones and altered goosecoid gene expression in the branchial region following retinoic acid treatment of mouse embryos in vivo
84. The mouse homolog of the region specific homeotic gene spalt of Drosophila is expressed in the developing nervous system and in mesoderm-derived structures
85. Prx1 and Prx2 in skeletogenesis: Roles in the craniofacial region, inner ear and limbs
86. Gammadelta T cell receptor repertoire in middle ear effusions in children
87. Adenovirus-mediated in vivo gene transfer in guinea pig middle ear mucosa
88. In vivo adenoviral transduction of the neonatal rat cochlea and middle ear